St. Jude scientists analyzed tumor samples from a 10-year clinical trial that studied medulloblastoma.
Enzyme LRRK2 is a biological switch whose mutation generates abnormal proteins in Parkinson’s patients.
Scientists at St. Jude looked at sequences of DNA to determine how they can destroy cancer cells that resist treatment.
St. Jude Children's Research Hospital scientists have helped advance a new therapy for sickle cell disease.
St. Jude Children’s Research Hospital provides the first gene therapy manufacturing and distribution cost report for hemophilia B.
A St. Jude analysis found a gap between the cost of manufacturing and distribution for hemophilia B gene therapy.
Scientists from St. Jude Children’s Research Hospital will present their original research and share their expertise at the American Society of Clinical Oncology (ASCO) annual meeting.
St. Jude, other top U.S. cancer centers call for urgent action to get cancer-preventing HPV vaccination on track
The COVID-19 pandemic has interrupted delivery of key health services for children and adolescents, including HPV vaccination for cancer prevention.
St. Jude director of Center of Excellence for Data Driven Discovery named a fellow of British medical association.
St. Jude scientists have developed a highly efficient method to address a major challenge in biology—identifying the genetic ‘switches’ that regulate gene expression.
Explore more research news
More Research News
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Browse all scientific publications by St. Jude investigators.